SPONSOR
Tianjin Medical University Cancer Institute and Hospital
Total Trials
14
Recruiting
14
Phases
Phase 2, Phase 1
Conditions studied: Gastric CancerEsophageal Squamous Cell CarcinomaPeripheral T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)NHL (Non-Hodgkin Lymphoma)Colorectal Cancer (CRC)Intrahepatic Cholangiocarcinoma (Icc)Locally Advanced Gastric AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaHepatocellular Carcinoma Non-resectable
NCT06102759
Recruiting
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
Gastric Cancer
NCT05490719 Phase 2
Recruiting
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
Esophageal Squamous Cell Carcinoma
NCT06914037 Phase 1
Recruiting
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
Peripheral T-cell Lymphoma
NCT07047560 Phase 2
Recruiting
Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
Colorectal Cancer (CRC)
NCT06721286 Phase 2
Recruiting
Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
NCT04908566 Phase 2
Recruiting
Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Locally Advanced Gastric Adenocarcinoma
NCT06472037 Phase 2
Recruiting
AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC
Locally Advanced Pancreatic Ductal Adenocarcinoma
NCT06375486 Phase 2
Recruiting
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
Hepatocellular Carcinoma Non-resectable
NCT07281157 Phase 2
Recruiting
Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Advanced Colorectal Cancer
NCT06496789 Phase 2
Recruiting
Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer
Gastric Adenocarcinoma
NCT06102746
Recruiting
Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma
Gastric Neuroendocrine Carcinoma
NCT05215665
Recruiting
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
Cholangiocarcinoma
NCT06417567
Recruiting
The Safety and Effectiveness of NEPA in Preventing Postoperative Nausea and Vomiting After General Anesthesia Gastrointestinal Cancer Surgery: A Single-Center Retrospective Study
General Anesthesia Gastrointestinal Cancer Surgery
NCT06404840 Phase 2
Recruiting
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
Pancreatic Cancer